These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11910863)

  • 21. Microsatellite instability in Muir-Torre syndrome.
    Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN
    Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.
    Rütten A; Burgdorf W; Hügel H; Kutzner H; Hosseiny-Malayeri HR; Friedl W; Propping P; Kruse R
    Am J Dermatopathol; 1999 Oct; 21(5):405-13. PubMed ID: 10535567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Muir-Torre syndrome].
    Jonas J; Kruse R; Bähr R
    Chirurg; 2002 Apr; 73(4):366-9. PubMed ID: 12063922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
    Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
    Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muir-Torre syndrome: a variant of the cancer family syndrome.
    Hall NR; Williams MA; Murday VA; Newton JA; Bishop DT
    J Med Genet; 1994 Aug; 31(8):627-31. PubMed ID: 7815421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
    Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
    J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sebaceous tumors and Muir-Torre syndrome].
    Bourlond F; Cribier B; Lipsker D; Velter C
    Ann Dermatol Venereol; 2015; 142(6-7):456-9. PubMed ID: 25890836
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome.
    Hall NR; Murday VA; Chapman P; Williams MA; Burn J; Finan PJ; Bishop DT
    Eur J Cancer; 1994; 30A(2):180-2. PubMed ID: 8155392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis.
    Southey MC; Young MA; Whitty J; Mifsud S; Keilar M; Mead L; Trute L; Aittomäki K; McLachlan SA; Debinski H; Venter DJ; Armes JE
    Am J Surg Pathol; 2001 Jul; 25(7):936-41. PubMed ID: 11420466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
    Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
    J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations.
    Ponti G; Ponz de Leon M; Maffei S; Pedroni M; Losi L; Di Gregorio C; Gismondi V; Scarselli A; Benatti P; Roncari B; Seidenari S; Pellacani G; Varotti C; Prete E; Varesco L; Roncucci L
    Clin Genet; 2005 Nov; 68(5):442-7. PubMed ID: 16207212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
    Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P
    Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.
    Cohen PR; Kohn SR; Kurzrock R
    Am J Med; 1991 May; 90(5):606-13. PubMed ID: 2029018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous Sebaceous Lesions in a Patient With MUTYH-Associated Polyposis Mimicking Muir-Torre Syndrome.
    Kacerovska D; Drlik L; Slezakova L; Michal M; Stehlik J; Sedivcova M; Hadravsky L; Kazakov DV
    Am J Dermatopathol; 2016 Dec; 38(12):915-923. PubMed ID: 27870730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muir-Torre syndrome: Diagnostic and screening guidelines.
    Jones B; Oh C; Mangold E; Egan CA
    Australas J Dermatol; 2006 Nov; 47(4):266-9. PubMed ID: 17034469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].
    Velter C; Bourlond F; Wettle C; Lioure B; Lipsker D; Maugard C; Cribier B
    Ann Dermatol Venereol; 2016 Dec; 143(12):825-830. PubMed ID: 27771121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muir-Torre syndrome.
    Lachiewicz AM; Wilkinson TM; Groben P; Ollila DW; Thomas NE
    Am J Clin Dermatol; 2007; 8(5):315-9. PubMed ID: 17902735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sebaceous hyperplasia of the lower eyelid].
    Spraul CW; Jakobczyk-Zmija MJ; Lang GK
    Klin Monbl Augenheilkd; 1999 Nov; 215(5):319-20. PubMed ID: 10609249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.